During the past decade, Hospital de Câncer de Londrina conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 2 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 2 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital de Câncer de Londrina" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Loxo Oncology, Inc." with 2 trials sponsored and "Incyte Corporation" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Câncer de Londrina" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Latin American Cooperative Oncology Group" with 1 trials as a collaborator, "NSABP Foundation Inc" with 1 trials as a collaborator and "Zai Lab (Shanghai) Co., Ltd." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de Câncer de Londrina" are "Breast Cancer" (3 trials), "Breast Neoplasms" (2 trials), "Neoplasm Metastasis" (2 trials), "Abiraterone Acetate" (1 trials) and "Androgens" (1 trials). Many other conditions were trialed in "Hospital de Câncer de Londrina" in a lesser frequency.

Most popular intervention types in "Hospital de Câncer de Londrina" are "Drug" (11 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (4 trials), "Carboplatin" (3 trials), "Pemetrexed" (3 trials), "Cisplatin" (2 trials) and "Exemestane" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Câncer de Londrina" are 13 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital de Câncer de Londrina". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hospital de Câncer de Londrina, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Câncer de Londrina, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Hospital de Câncer de Londrina has several departments that took part in Clinical trials: "Instituto Do Cancer Delondrina_X; Unidade De Pesquisa Clinica" - 2 trials